Global Obesity Management Industry Analysis, Trends and Opportunity Assessment


Posted August 21, 2017 by markengine

More than half a billion people were found to be obese and almost 2 billion adults were spotted as overweight. Surprisingly, it works out that 13% of the global population is obese and 39% are overweight.

 
In the present day scenario, lifestyle diseases such as diabetes and other chronic ailments are seen as the primary cause of obesity around the world. Further, it has been analyzed that, geriatric people are far more prone to conceal sarcopenia, which is a noticeable rise in body fat. This fact makes them a significant segment of the global obesity management market, which is studied through a report added to the wide database of Market Research Reports Search Engine (MRRSE). The research report is titled “Obesity Management Market: Global Industry Analysis and Opportunity Assessment 2017-2027”, which discusses market size and growth forecast for the coming years until 2027. Further, regional segmentation is also enclosed in this smart report which works to educate the readers in a precise manner.

Request for sample report: http://www.mrrse.com/sample/3228

It has been noted that the prevalence of obesity has nearly doubled in the past years since 1980. As per statistics in 2014, more than half a billion people were found to be obese and almost 2 billion adults were spotted as overweight. Surprisingly, it works out that 13% of the global population is obese and 39% are overweight. Hence, this calls out for obesity management on a global level to curb this issue. The research study starts with a clear canvas which comprises the market definition and market taxonomy. Further, this section also includes the market size (US$ Mn) and forecast for the period until 2027. Factors such as Y-o-Y growth and Absolute $ Opportunity can be easily gathered from this intelligent report. Readers are also enlightened with deep information about the market influencing facets such as drivers, restraints, opportunity, and trends.

The following section talks about the various segregations in the global obesity management market. Based on drug type, the market includes Lorcaserin, Phentermine and Topiramate, Bupropion and Naltrexone, Orlistat and Liraglutide. Further, on the basis of surgery type, Gastric Bypass Surgery, Duodenal Switch Surgery, Adjustable Gastric Banding Surgery and Gastric Sleeve Surgery are seen as the prime segregations. The geographical expanse of the global obesity management market is spread across North America, Western Europe, Eastern Europe, Latin America, APEJ, Japan, and MEA. For each of the mentioned segmentations, BPS analysis, market value forecast and Y-o-Y growth are carefully added to the research study.

As per research findings, North America is forecasted to account for more than 1/3rd revenue share of the overall obesity management market by the end of the year 2017. At this pace, it is projected to gain a substantial 224 BPS by the year 2027. 

Browse Full Report with TOC : http://www.mrrse.com/obesity-management-market

About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower 
90, State Street 
Suite 700 
Albany, NY - 12207 
United States

Telephone: +1-518-730-0559 
Email: [email protected]

Website: http://www.mrrse.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By MRRSE
Phone +1-518-730-0559
Business Address State Tower 90, State Street Suite 700
Albany, NY - 12207 United States
Country United States
Categories Health
Tags chronic , diabetes , obesity , pharmaceutical
Last Updated August 21, 2017